Real ‐world effectiveness of mepolizumab in severe asthma and chronic rhinosinusitis in the United States: impact of comorbidity and sinus surgery

ConclusionsConsistent with trial data, mepolizumab use in real-world practice shows benefits across comorbid patient cohorts with more a pronounced impact in those with severe asthma+comorbid CRS  + sinus surgery.

Source: International Forum of Allergy and Rhinology - July 20, 2023 Category: Allergy & Immunology Authors: Jared Silver, Arijita Deb, Fran çois Laliberté, Chi Gao, Neil Bhattacharyya Tags: ORIGINAL ARTICLE Source Type: research